Overcoming the impact of increasingly diverse reporting requirements on pharmacovigilance

Thursday, 27 April, 4PM-5PM CET



The COVID-19 pandemic accentuated the need for safety organizations to advance their methods of adverse event data processing and analysis in the face of increasingly diverse reporting requirements in different regions. Post-pandemic it’s more important than ever to rapidly access and analyse AE information, gain meaningful data insights, and understand the impact on product safety processes.

Addressing these challenges, the ever-evolving E2B(R3) and IDMP standards are intended to capture detailed standardized AE and medicinal product data, enable communication and collaboration amongst safety professionals, and ultimately provide patients and consumers with greater protection.


In this webinar we will explore:

  • Various regional approaches – from traditional to innovative – in implementing E2B(R3) and IDMP
  • Challenges in producing a single ICSR which adheres to various regional regulatory requirements worldwide.
  • Advancements in electronic ICSR reporting and its impact on compliance.


This webinar is applicable to:

  • VPs and QPPVs of safety
  • Case processing specialists
  • Safety evaluators
  • Safety IT professionals
  • Safety managers






Get Involved At World Drug Safety Congress

Conference Production

George Mullens
+44 20 8164 3940 


Sponsorship & Exhibition Sales

Rohit Dhap
+44 20 8164 3001


Marketing Opportunities

Diana Cobzac
+44 20 3545 5512